eISSN 2097-6054 ISSN 1672-9234 CN 11-5289/R
Responsible Institution:China Association for Science and Technology
Publishing:Chinese Nursing Journals Publishing House Co.,Ltd.
Sponsor:Chinese Nursing Association
Source journal for Chinese Science Citation Database
China Academic Journals Full-text Database
China Core Journal Alternative Database
Scopus
Clinical Practice

A longitudinal study on the change trajectory and influencing factors of wound symptom distress in patients with malignant fungating wounds

  • Xin LIU ,
  • Hua LIN ,
  • Ting ZHANG ,
  • Ling SHEN
Expand

Received date: 2021-08-24

  Online published: 2022-07-22

Abstract

Objective To understand the change trajectory and influencing factors of wound symptom distress at different times after the diagnosis of malignant tumor wound. Methods A longitudinal study design was used to evaluate patients’ wound symptom distress at the time of pathological diagnosis (T1),1 month after diagnosis (T2),3 months after diagnosis(T3),and 6 months after diagnosis (T4). The distress in different periods was compared and the influencing factors of symptom distress were analyzed. Results The wound Symptom Intrusiveness score:T1 (49.20±13.78),T2 (57.71±13.47),T3 (45.58±13.69),and T4 (43.79±12.98). Treatment stage,gender,wound exudation,wound odor,wound pruritus and dressing change frequency were the influencing factors of wound symptoms distress. Conclusion The trajectory of wound symptom distress in patients with malignant fungating wounds firstly going high then becoming low. Early evaluation,continuous follow-up and whole process symptom management of patients with malignant fungating wounds should be strengthened to reduce wound symptoms and improve the quality of life of patients.

Cite this article

Xin LIU , Hua LIN , Ting ZHANG , Ling SHEN . A longitudinal study on the change trajectory and influencing factors of wound symptom distress in patients with malignant fungating wounds[J]. Chinese Journal of Nursing Education, 2022 , 19(7) : 652 -656 . DOI: 10.3761/j.issn.1672-9234.2022.07.014

References

[1] Grocott P, Gethin G, Probst S. Malignant wound management in advanced illness:new insights[J]. Curr Opin Support Palliat Care, 2013, 7(1):101-105.
[2] American Cancer Society. Cancer Facts and Figures[EB/OL].(2017-12-22).https://www.cancer.org/research/cancer-facts-statis-tics/all-cancer-facts-figures/cancer-facts-figures-2017.html .
[3] Tilley CP, Fu MR, Qiu JM,et al. The microbiome and meta-bolome of malignant fungating wounds[J]. J Wound Ostomy Cont Nurs, 2021, 48(2):124-135.
[4] Tandler S, Stephen-Haynes J. Fungating wounds:management and treatment options[J]. Br J Nurs, 2017, 26(12 Suppl):S6-S14.
[5] Tilley C, Lipson J, Ramos M. Palliative wound care for malignant fungating wounds:holistic considerations at end-of-life[J]. Nurs Clin North Am, 2016, 51(3):513-531.
[6] Monfre JM, Kelechi TJ, Magwood GS,et al. Development and psychometric evaluation of the symptom intrusiveness rating scale among individuals experiencing pain associated with chronic wounds[J]. J Wound Ostomy Continence Nurs, 2015, 42(5):474-479.
[7] 李孟喜, 柏素萍, 魏青. 中文版症状生活干扰评估量表在慢性伤口疼痛患者中的信效度检验[J]. 中国实用护理杂志, 2018, 34(31):2414-2417.
[7] Li MX, Bai SP, Wei Q. Reliability and validity of Chinese version of Symptom Intrusiveness Rating Scale among patients experiencing pain associated with chronic wound[J]. Chin J Pract Nurs, 2018, 34(31):2414-2417.
[8] Naylor W. Symptom control in the management of fungating wounds[EB/OL].[2020-11-02]. http://www.worldwidewounds.com/2002/march/Naylor/Symptom-Control-Fungating-Wounds.html .
[9] Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale[J]. Pain, 1983, 16(1):87-101.
[10] Lo SF, Hu WY, Hayter M,et al. Experiences of living with a malignant fungating wound:a qualitative study[J]. J Clin Nurs, 2008, 17(20):2699-2708.
[11] Gramling R, Ingersoll LT, Anderson W,et al. End-of-life pref-erences,length-of-life conversations,and hospice enrollment in palliative care:a direct observation cohort study among people with advanced cancer[J]. J Palliat Med, 2019, 22(2):152-156.
[12] Cornish L. Holistic management of malignant wounds in palliative patients[J]. Br J Community Nurs, 2019, 24(9):S19-S23.
[13] Probst S,Arber A,Faithfull S.Probst S,Arber A,Faithfull S. Malignant fungating wounds:the meaning of living in an unbounded body[J]. Eur J Oncol Nurs,2013, 17(1):38-45.
[14] Winardi A, Irwan AM. Topical treatment for controlling malignant wound odour[J]. Journal EWMA (JEWMA), 2019, 20 (2):7-13.
[15] European Oncology Nursing Society(EONS). Recommendations for the care of patients with malignant fungating wounds(2015)[EB/OL].[2019-11-18]. https://www.cancernurse.eu/do-cuments/EONS Malignant Fungating Wounds.pdf
[16] 周帅, 江锦芳, 覃彦珠,等. 恶性肿瘤伤口症状管理的最佳证据总结[J]. 护理学杂志, 2020, 35(20):92-97.
[16] Zhou S, Jiang JF, Qin YZ,et al. Summary of best evidence regarding symptoms management of malignant fungating wounds[J]. J Nurs Sci, 2020, 35(20):92-97.
Outlines

/